Osteoporosis risk assessment

BMJ (Online)

Volumn 345, Issue 7864, 2012, Pages

  Cooper, Cyrus ^a   Harvey, Nicholas C ^a  

^a UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BONE DENSITY; CLINICAL ASSESSMENT TOOL; COUPLAND; EDITORIAL; FRACTURE; GENERAL PRACTICE; HIPPISLEY COX; HUMAN; MEDICAL DECISION MAKING; OSTEOPOROSIS; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; RISK REDUCTION; ALGORITHM; FEMALE; FRAGILITY FRACTURE; HIP FRACTURE; MALE; NOTE; PRIMARY HEALTH CARE;

ALGORITHMS; FEMALE; HIP FRACTURES; HUMANS; MALE; OSTEOPOROTIC FRACTURES; PRIMARY HEALTH CARE;

EID: 84863586943     PISSN: None     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.e4191     Document Type: Editorial

References (9)

1. Hippisley-Cox J, Coupland C. Derivation and validation of updated QFracture algorithm to predict risk of osteoporotic fracture in primary care in the United Kingdom: prospective open cohort study. 2012;344:e3427
2. Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. Report of a WHO Study Group. WHO Tech Rep Ser 1994;843:1-129.
3. Kanis JA, McCloskey EV, Johansson H, Strom O, Borgstrom F, Oden A. Case finding for the management of osteoporosis with FRAX-assessment and intervention thresholds for the UK. Osteoporos Int 2008;19:1395-408.
4. Hippisley-Cox J, Coupland C. Predicting risk of osteoporotic fracture in men and women in England and Wales: prospective derivation and validation of QFracture scores. BMJ 2009;339:b4229.
5. National Institute for Health and Clinical Excellence. Osteoporosis: fragility fracture risk. Short clinical guideline-evidence and recommendation. 2012. www.nice.org.uk/nicemedia/live/13281/58077/58077.pdf.
6. Van Staa TP, Geusens P, Kanis JA, Leufkens HG, Gehlbach S, Cooper C. A simple clinical score for estimating the long-term risk of fracture in post-menopausal women. QJM 2006;99:673-82. (Pubitemid 44542316)
7. Kanis JA, Hans D, Cooper C, Baim S, Bilezikian JP, Binkley N, et al. Interpretation and use of FRAX in clinical practice. Osteoporos Int 2011;22:2395-411.
8. National Institute for Health and Clinical Excellence. Alendronate, etidronate, risedronate, raloxifene and strontium ranelate for the primary prevention of osteoporotic fragility fractures in postmenopausal women (amended). TA160. 2011. www.nice.org.uk/nicemedia/live/11746/47176/47176.pdf
9. Compston JE, Cooper A, Cooper C, Francis R, Kanis JA, Marsh D, et al. Guidelines for the diagnosis and management of osteoporosis in postmenopausal women and men aged 50 years and over in the UK. Maturitas 2009;62:105-8.